Skip to main content
Top
Published in: Digestive Diseases and Sciences 5/2010

01-05-2010 | Original Article

Association Between Small Intestinal Bacterial Overgrowth and Peripheral Bacterial DNA in Cirrhotic Patients

Authors: Dae Won Jun, Kyung Tae Kim, Oh Young Lee, Jeong Don Chae, Byoung Kwan Son, Seong Hwan Kim, Yun Ju Jo, Young Sook Park

Published in: Digestive Diseases and Sciences | Issue 5/2010

Login to get access

Abstract

Background

Small intestinal bacterial overgrowth (SIBO) is regarded as the major risk factor of bacterial translocation. Few studies have investigated the direct relation between SIBO and translocation in cirrhotic patients. The purpose of this study is to examine the correlation between SIBO and bacterial DNA in the peripheral blood of patients with cirrhosis.

Aims

The purpose of this study is to examine the correlation between SIBO and bacterial DNA in the peripheral blood of patients with cirrhosis.

Methods

Fifty-three cirrhosis cases and 42 controls underwent a lactulose breath test (LBT) every 15 min for 180 min. To detect and identify the presence of bacterial DNA fragments in peripheral blood, multiplex polymerase chain reaction (PCR) was performed.

Results

The positive rate of LBT was significantly different between the two groups: 60.4% in the patient group and 28.6% in the controls. The SIBO positive rate was 81.3% in the cirrhosis patients with ascites, which was significantly higher than 51.4% in the cirrhosis patients with no ascites (P = 0.03). Eight of the nine patients (88.9%) who had a history of one or more hepatic encephalopathy was SIBO-positive, which was higher than the patients who had had no hepatic encephalopathy. In the cirrhosis group, 32 patients (60.4%) were SIBO-positive, and ten of them (31.3%) were bacterial DNA-positive. Only one case (4.8%) was bacterial DNA-positive in the absence of SIBO-positive. In a multivariate analysis, only the existence of SIBO was the independent risk factor for bacterial DNA (P = 0.026).

Conclusions

SIBO in cirrhosis patients was observed at a very high frequency, and SIBO showed a high correlation with bacterial translocation, suggesting that SIBO could be a major risk factor of bacterial translocation, especially in ascitic patients.
Literature
3.
go back to reference Gou YZ, Lian JQ, Nie QH. Bacterial translocation and its consequences in patients with liver cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 2006;14:796–797.PubMed Gou YZ, Lian JQ, Nie QH. Bacterial translocation and its consequences in patients with liver cirrhosis. Zhonghua Gan Zang Bing Za Zhi. 2006;14:796–797.PubMed
4.
go back to reference Francés R, González-Navajas JM, Zapater P, et al. Translocation of bacterial DNA from Gram-positive microorganisms is associated with a species-specific inflammatory response in serum and ascitic fluid of patients with cirrhosis. Clin Exp Immunol. 2007;150:230–237.PubMed Francés R, González-Navajas JM, Zapater P, et al. Translocation of bacterial DNA from Gram-positive microorganisms is associated with a species-specific inflammatory response in serum and ascitic fluid of patients with cirrhosis. Clin Exp Immunol. 2007;150:230–237.PubMed
9.
go back to reference González-Navajas JM, Francés R, Such J. Bacterial DNA in patients with cirrhosis and sterile ascites. Its role as a marker of bacterial translocation and prognostic tool. Rev Esp Enferm Dig. 2007;99:599–603.CrossRefPubMed González-Navajas JM, Francés R, Such J. Bacterial DNA in patients with cirrhosis and sterile ascites. Its role as a marker of bacterial translocation and prognostic tool. Rev Esp Enferm Dig. 2007;99:599–603.CrossRefPubMed
10.
go back to reference Guarner C, González-Navajas JM, Sánchez E, et al. The detection of bacterial DNA in blood of rats with CCI4-induced cirrhosis with ascites represents episodes of bacterial translocation. Hepatology. 2006;44:633–639. doi:10.1002/hep.21286.CrossRefPubMed Guarner C, González-Navajas JM, Sánchez E, et al. The detection of bacterial DNA in blood of rats with CCI4-induced cirrhosis with ascites represents episodes of bacterial translocation. Hepatology. 2006;44:633–639. doi:10.​1002/​hep.​21286.CrossRefPubMed
11.
go back to reference Hwang IT, Kim YJ, Kim SH, et al. Annealing control primer system for improving specificity of PCR amplification. Biotechniques. 2003;35:1180–1184.PubMed Hwang IT, Kim YJ, Kim SH, et al. Annealing control primer system for improving specificity of PCR amplification. Biotechniques. 2003;35:1180–1184.PubMed
13.
go back to reference Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003;98:412–419.PubMed Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. A double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003;98:412–419.PubMed
14.
go back to reference Paik CN, Choi MG, Nam KW, et al. The prevalence of small intestinal bacterial overgrowth in Korean patients with irritable bowel syndrome. Kor J Neurogastroenterol Motil. 2007;13:38–44. Paik CN, Choi MG, Nam KW, et al. The prevalence of small intestinal bacterial overgrowth in Korean patients with irritable bowel syndrome. Kor J Neurogastroenterol Motil. 2007;13:38–44.
15.
go back to reference Bauer TM, Schwacha H, Steinbrückner B, et al. Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: Poor performance of the glucose breath hydrogen test. J Hepatol. 2000;33:382–386. doi:10.1016/S0168-8278(00)80273-1.CrossRefPubMed Bauer TM, Schwacha H, Steinbrückner B, et al. Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: Poor performance of the glucose breath hydrogen test. J Hepatol. 2000;33:382–386. doi:10.​1016/​S0168-8278(00)80273-1.CrossRefPubMed
18.
go back to reference Kim YJ, Kwak CI, Gu YY, et al. Annealing control primer system for identification of differentially expressed genes on agarose gels. Biotechniques. 2004;36:424–6, 428, 430 passim. Kim YJ, Kwak CI, Gu YY, et al. Annealing control primer system for identification of differentially expressed genes on agarose gels. Biotechniques. 2004;36:424–6, 428, 430 passim.
19.
go back to reference Chun JY, Kim KJ, Hwang IT, et al. Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene. Nucleic Acids Res. 2007;35:e40. doi:10.1093/nar/gkm051.CrossRefPubMed Chun JY, Kim KJ, Hwang IT, et al. Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene. Nucleic Acids Res. 2007;35:e40. doi:10.​1093/​nar/​gkm051.CrossRefPubMed
22.
go back to reference Francés R, Zapater P, González-Navajas JM, et al. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology. 2008;47:978–985. doi:10.1002/hep.22083.CrossRefPubMed Francés R, Zapater P, González-Navajas JM, et al. Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis. Hepatology. 2008;47:978–985. doi:10.​1002/​hep.​22083.CrossRefPubMed
Metadata
Title
Association Between Small Intestinal Bacterial Overgrowth and Peripheral Bacterial DNA in Cirrhotic Patients
Authors
Dae Won Jun
Kyung Tae Kim
Oh Young Lee
Jeong Don Chae
Byoung Kwan Son
Seong Hwan Kim
Yun Ju Jo
Young Sook Park
Publication date
01-05-2010
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 5/2010
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-009-0870-9

Other articles of this Issue 5/2010

Digestive Diseases and Sciences 5/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.